A universal respiratory syncytial virus (RSV) immunization program using Sanofi’s Beyfortus (nirsevimab) was associated with ...

Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV ...

One bill in our legislative session that was getting a lot of attention, at least with respect to written testimony, is Senate Bill 1434, Relating to Universal Immunization Funding Program. This bill ...

Each year, the World Health Organization (WHO) partakes in World Immunization Week, a period of reflection, raising awareness, and future planning surrounding global action required to combat ...